News
March 11, 2008 – Medtronic Inc. will feature its newly FDA-cleared Endeavor Zotarolimus-Eluting Coronary Stent System ...
March 10, 2008
Feature | Richard R. Rogoski
Choosing the right device to regulate or jump-start the heart can be a challenge. Not only does a patient’s symptoms often dictate whether a pacemaker or defibrillator is a more appropriate treatment, but new advances in technology are making the choice between available devices more difficult.
March 10, 2008
Technology
Bayer HealthCare Pharmaceuticals Inc. offers VistaTrak, a contrast media management system that provides a new ...
March 10, 2008Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025News
March 10, 2008 – The Medical Imaging & Technology Alliance (MITA), a division of NEMA, today praised the 88 Members of ...
March 10, 2008News
March 11, 2008 - St. Jude Medical Inc. received regulatory approval from the Ministry of Health, Labor and Welfare (MHLW ...
March 10, 2008
Technology
Zollï's E Series defibrillators with a 12-lead reportedly offer a variety of transmission solutions and can be tailored ...
March 10, 2008Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025News
March 11, 2008 - Abbott announced today that it has received CE Mark (Conformite Europeene) approval for a 2.25 mm ...
March 10, 2008
Technology
Fujifilm will highlight the newest CVIIS release Version 4.0 from ProSolv Cardiovascular. This release, which integrates ...
March 10, 2008News
March 11, 2008 - Cardiac Science Corp. completed a delivery of 282 electrocardiograph systems (ECGs) to Mexico’s Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), representing the single largest ECG order in Cardiac Science history.
March 10, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Feature | Bess-Catherine McCord
Sometimes the smallest changes in technology can have a huge impact, and in healthcare, this means improved patient ...
March 10, 2008
Technology
Sorin Group's ELA Medical markets ISOLINE, a defibrillation lead designed with redundant insulation and abrasion resistant materials for longevity and safety.
March 10, 2008News
March 11, 2008 – Bayer HealthCare Pharmaceuticals Inc. unveiled plans to launch VistaTrak, a contrast media management ...
March 10, 2008Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Technology
NovaRad’s NovaPACS Cardio Viewer offers sign-on access to images or over a Web site. Features in this module include ...
March 10, 2008News
March 11, 2008 - Sorin Group's ELA Medical received the FDA’s approval to market ISOLINE, a new defibrillation lead designed with redundant insulation and abrasion resistant materials for longevity and safety, in a move that strengthens the company’s position in the U.S. market.
March 10, 2008Feature | Anthony Sanzo, CEO of TeleTracking Technologies,
The recent revelation that MRSA is killing more Americans than AIDs compels us to look for better answers, and fast. A ...
March 10, 2008